11 First Eagle Investments AdaptHealth Trades
First Eagle Investments's position in AdaptHealth is currently worth $7.35 Million. That's 0.02% of their equity portfolio (194th largest holding). The first AdaptHealth trade was made in Q2 2022. Since then First Eagle Investments bought shares six more times and sold shares on four occasions. The investor's estimated purchase price is $9.73 Million, resulting in a loss of 24%.
Avg closing price
Price range
Sold 7.9% shares (-73.3 Thousand shares)
Q4 2024
Avg closing price
$10.13
Price range
$9.18
-
$11.00
Increased shares by 3.6% (+32.7 Thousand shares)
Q3 2024
Avg closing price
$10.62
Price range
$8.66
-
$11.53
Increased shares by 50.9% (+303 Thousand shares)
Q2 2024
Avg closing price
$10.16
Price range
$9.19
-
$11.60
Increased shares by 18.2% (+91.8 Thousand shares)
Q1 2024
Avg closing price
$8.49
Price range
$6.64
-
$11.51
Increased shares by 22.6% (+92.8 Thousand shares)
Q4 2023
Avg closing price
$7.88
Price range
$6.49
-
$9.20
Increased shares by 88.7% (+193 Thousand shares)
Q3 2023
Avg closing price
$11.99
Price range
$8.60
-
$14.77
Increased shares by 124.3% (+121 Thousand shares)
Q2 2023
Avg closing price
$11.14
Price range
$9.43
-
$12.52
Sold 5.4% shares (-5.5 Thousand shares)
Q1 2023
Avg closing price
$18.40
Price range
$12.43
-
$22.73
Sold 10.5% shares (-12 Thousand shares)
Q4 2022
Avg closing price
$21.14
Price range
$19.02
-
$23.00
Sold 36.0% shares (-64.3 Thousand shares)
Q3 2022
Avg closing price
$20.55
Price range
$17.38
-
$25.72
New holding (+179 Thousand shares)
Q2 2022
Avg closing price
$16.24
Price range
$11.43
-
$19.27
